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Abstract
Background: The diabetes of many patients is managed in general practice; healthcare providers
aim to promote healthful behaviors, such as healthful diet, adequate physical activity, and smoking
cessation. These measures may decrease insulin resistance, improve glycemic control, lipid
abnormalities, and hypertension. They may also prevent cardiovascular disease and complications
of diabetes. However, professionals do not adhere optimally to guidelines for lifestyle counseling.
Motivational interviewing to change the lifestyle of patients with type 2 diabetes is intended to
improve diabetes care in accordance with the national guidelines for lifestyle counseling. Primary
care nurses will be trained in motivational interviewing embedded in structured care in general
practice. The aim of this paper is to describe the design and methods of a study evaluating the
effects of the nurses' training on patient outcomes.
Methods/Design:  A cluster, randomized, controlled trial involving 70 general practices (35
practices in the intervention arm and 35 in the control arm) starting in March 2007. A total of 700
patients with type 2 diabetes will be recruited. The patients in the intervention arm will receive
care from the primary care nurse, who will receive training in an implementation strategy with
motivational interviewing as the core component. Other components of this strategy will be
adaptation of the diabetes protocol to local circumstances, introduction of a social map for lifestyle
support, and educational and supportive tools for sustaining motivational interviewing. The control
arm will be encouraged to maintain usual care. The effect measures will be the care process,
metabolic parameters (glycosylated hemoglobin, blood pressure and lipids), lifestyle (diet, physical
activity, smoking, and alcohol), health-related quality of life, and patients' willingness to change
behaviors. The measurements will take place at baseline and after 14 months.
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Discussion: Applying motivational interviewing for patients with diabetes in primary care has been
studied, but to our knowledge, no other study has yet evaluated the implementation and
sustainability of motivating and involving patients in day-to-day diabetes care in general practice. If
this intervention proves to be effective and cost-effective, large-scale implementation of this nurse-
oriented intervention will be considered and anticipated.
Trial registration: Current Controlled Trials ISRCTN68707773.
Background
Professionals' performance in lifestyle counseling is sub-
optimal, yet it is very important that healthcare providers
promote healthful behaviors for patients with type 2 dia-
betes[1,2]. There are studies indicating that healthful diet
and physical activity decrease insulin resistance and
improve glycemic control, lipid abnormalities, and hyper-
tension, thereby lowering the risk of cardiovascular dis-
ease (CVD) [3-6]. Smoking is known to be particularly
dangerous; it doubles the risk of CVD for those with and
without diabetes[7]. Lifestyle counseling requires more
focused support for professionals so that they can ade-
quately support their patients[8,9].
With the increasing prevalence of diabetes due to aging
and the increasing average weight in the population, the
problems of lifestyle counseling are becoming more
urgent[9]. Diabetes mellitus is a major cause of morbidity
and mortality worldwide. About half a million people are
known to have diabetes in the Netherlands, and this
number is expected to increase by 36% in the next 20
years[10]. The age- and sex-adjusted prevalence of type 2
diabetes is 2.9%; 3.1% for women and 2.7% for men[11].
Patients aged more than 70 years account for almost 50%
of all patients with type 2 diabetes [11].
Effective diabetes care is based on two elements: struc-
tured care and a patient-centered approach [12-14]. These
elements lead to improvements of patient outcomes and
process outcomes, and they play an important role in life-
style counseling for diabetes patients [15-17]. In the Neth-
erlands, diabetes care is provided mainly in primary care
(80–90%), and in most practices, a primary care nurse has
the tasks of providing lifestyle counseling in a structured
manner and involving patients in managing their dis-
ease[18,19]. Nevertheless, some studies suggest that many
healthcare providers, nurses included, lack the skills to
promote lifestyle change [20-24]. A practical tool such as
the patient-oriented counseling technique of motiva-
tional interviewing (MI) can contribute to implementing
the lifestyle recommendations[20,25]. Controlled trials in
general practices have shown that MI is an effective strat-
egy in the treatment of various diseases [26-30]. However,
just training primary care nurses in MI will not be suffi-
cient; it is important to embed MI in an implementation
strategy[13].
There is a wide range of implementation strategies aimed
at improving the provision of diabetes care in primary
care. Multifaceted professional interventions (such as
counseling, auditing, and feedback) and organizational
interventions (such as revision of professional roles,
changes in medical record systems, and arrangements for
follow-up) that facilitate the structured and regular review
of patients have proven to be effective in improving
care[13]. However, very few studies have focused on inte-
grating some of these implementation strategies effec-
tively into professional behavior in daily work in general
practice.
Our Motivational Interviewing to Change the Lifestyle of
Patients with Type 2 Diabetes (MILD) Study is intended to
improve type 2 diabetes care in accordance with the
national guidelines for lifestyle counseling by having pri-
mary care nurses, who will be trained in lifestyle MI and
who will implement structured care in general practice.
The impact of the implementation strategy will be evalu-
ated in various ways. First, the effect of the implementa-
tion strategy on the nurses' care and the relevant patient
outcomes will be examined and compared with those of
usual care. Second, there will be a process evaluation of
the exposure of the implementation strategy and its feasi-
bility. Third, since this study will determine both the
effects and the costs of the implementation strategy, we
plan to evaluate it economically to establish the cost-effec-
tiveness. The aim of this study protocol is to describe the
design and methods of a study to evaluate the effects,
costs, process, and cost-effectiveness of an implementa-
tion strategy for motivating and involving patients in life-
style issues as a part of their diabetes management.
Our research questions will be:
1. What is the effect of an implementation strategy aimed
at the routine MI by primary care nurses compared to
usual care with regard to:BMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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(a) The care process
(b) The metabolic parameters, such as glycosylated hemo-
globin (HbA1c), blood pressure, and lipids
(c) Lifestyle changes; diet, exercise, smoking, and alcohol
consumption
(d) Health-related quality of life
(e) Patients' willingness to change behaviors? [Effect eval-
uation]
2. To what extent do primary care nurses take part in the
implementation strategy, and is the strategy feasible in the
view of patients and nurses? [Process evaluation]
3. What is the incremental cost-effectiveness ratio of our
implementation strategy compared with that of the usual
care of a primary care nurse? [Economic evaluation]
Methods/Design
Study design
The study is a cluster, randomized, controlled trial involv-
ing 70 general practices and 700 patients with type 2 dia-
betes in the Netherlands. Each practice is staffed with a
primary care nurse who will be allocated to either:
- The control arm of practices in which patients with dia-
betes receive only usual care from the primary care nurse.
- The intervention arm of practices in which patients with
diabetes receive care from nurses who will be skilled in MI
and authorized to use it.
We will include all appointments for each patient (the
guidelines require four appointments), so that each
patient will be followed for 14 months.
Ethical approval and informed consent
The Medical Ethics Committee of the University of
Nijmegen has granted ethical approval. The trial is regis-
tered as ISRCTN68707773[31]. The general practitioner
(GP) and the research team will send a letter of informa-
tion about the project to each eligible patient. The privacy
of the participating patients will be protected, and all data
will be coded and processed anonymously. It will be
made clear in the informed consent form that each patient
can stop his of her participation in the study at any
moment without any consequence for the quality of his or
her usual diabetes care. The patient will be asked to sign
the informed consent form and return it to Nijmegen Uni-
versity to allow further contact regarding the research.
Recruitment of general practices and patients
The trial will be carried out with general practices and
their patients with diabetes. Figure 1 shows the pathway
with which general practices and patients will be
recruited.
General practices
Practices in the south of the Netherlands will receive a let-
ter of invitation with an information leaflet about the
study. General practices that do not employ a primary care
nurse will be excluded from the study. A member of the
research team (RJ) will visit all practices that express their
intention to participate. At least one GP and the primary
care nurse of a practice willing to participate will be
present during the appointment. We will explain the
study in detail and provide them with a full information
package describing the aims, methods, and expected out-
comes of the study. Nonresponders will be reminded by
letter 4 weeks later. Invitation letters will be sent in several
rounds until we find 70 general practices that will partici-
pate.
Patients
Patients with type 2 diabetes type will be eligible to partic-
ipate if they are younger than 80 years, their most recent
(frequently no longer than a year ago) HbA1c concentra-
tion is more than 7.0%, their body mass index is more
than 25 kg/m2, and they are receiving care from a general
practice that employs a primary care nurse. Patients with
complex coexisting medical conditions (e.g. mental ill-
ness or end-stage cancer) and those being treated by an
internist will be excluded. Two members of the research
team will make a list of all eligible patients in the partici-
pating practices by extracting means data from medical
files. Each of these patients will be sent a letter with the
GP's invitation to participate in the study. The letter will
include information about the design of the study, confi-
dentiality of data, the voluntary character of participation,
a questionnaire, and the informed consent form. The
patients will be asked to respond by returning the signed
informed consent form and the completed questionnaire
to the research team. Four weeks later, a reminder will be
sent to patients who have not responded. Nonresponders
will be asked to give their reasons for not participating, so
that we can compare the participating and nonparticipat-
ing groups.
Randomization
General practices will be the unit of randomization. An
independent person at Radboud University will centrally
randomize the 70 general practices in a randomized block
design, after the type of practice and urbanization level
have been stratified.BMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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Flowchart of the process for recruiting general practices and patients with diabetes Figure 1
Flowchart of the process for recruiting general practices and patients with diabetes.BMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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Sample size
In a regular practice, the proportion of patients with dia-
betes who have an HbA1c concentration greater than 7.0%
is about 48%[32]. Lifestyle intervention studies have con-
sistently shown that modest changes in the HbA1c con-
centration can reduce the progression from impaired
glucose tolerance to diabetes by about 50%[33]. There-
fore, we will aim our program to reduce the proportion
from 48% to 24% (50% relative risk reduction). With five
patients in each practice, 30 practices in each arm of the
study will be needed, if we assume an intercluster correla-
tion of no more than 0.05[34], and set alpha at 0.05 and
beta at 0.20.
We also calculated our power on another main outcome;
the extent to which patients participate, or are willing to
participate, in a program of diet, exercise, and smoking
cessation. We predict that the willingness to participate in
such a program can at least be tripled on the basis of com-
parable results of intensive stop-smoking programs in
general practice[35]. Just as in smoking cessation studies,
we assume that the success of lifestyle counseling in usual
care is 5% (relative risk reduction). A power calculation
based on the these assumptions shows that we need a
total of 68 practices (34 in each arm), with 5 patients in
each practice for an implementation strategy based on MI.
To answer the research questions, we will take a random
sample from the target group; and to take dropout into
account, we will include 35 practices in each arm with 10
patients in each practice. Recruitment of 70 practices (700
patients) will be feasible.
Control group conditions/usual care
The primary care nurses in the control group will not have
access to the implementation strategy. They will be
offered an opportunity to join the training program at the
end of the study. The nurses will be instructed to admin-
ister usual care consistent with current diabetes guide-
lines. These guidelines state that, in usual care, the GP
pays attention to complaints, glucose regulation, current
cardiovascular risk, and the early identification of compli-
cations. Patients without complaints and with good met-
abolic regulation will be invited to check-ups every 3
months. Once a year, the GP will pay extra attention to
specific items noted during the consultations[18].
Three-monthly check-ups
At the check-up, the GP will ask about well-being, symp-
toms that indicate hyperglycemia or hypoglycemia, com-
plications in diet and exercise counseling, and
medication. The GP will note the patient's weight. The
fasting blood glucose value will also be determined every
3 months[18].
Annual check-ups
The annual check-up will be extensive. The GP will ask
about eye complications, cardiovascular problems, sexual
problems, possible causes of and options for treatment,
etc. Furthermore, lifestyle counseling (about smoking,
physical activity, and alcohol use), physical examination
(body weight, blood pressure, and condition of the feet),
chronic complications, and laboratory research will be
reviewed. The laboratory work will provide values for the
fasting glucose, HbA1c, creatinine concentration and
clearance, lipid spectrum, and urine albumin/creatinine
ratio (or albumin concentration)[18].
The intervention
In addition to instruction for adhering to the prevailing
guidelines for diabetes care as described in usual care, the
primary care nurses in the intervention practices will
receive information about the various components of the
implementation strategy: (1) training in MI, (2) adapting
the diabetes protocol to local circumstances, (3) introduc-
ing a social map for support of lifestyle change, and (4)
practice tools for maintaining the training program (Addi-
tional file 1). The "diabetes protocol", "social map" and
"MI training" will be components of the training pro-
gram, which consists of 4 half-day training sessions spread
over the 1st half year. Primary care nurses will attend these
sessions in groups of 5 to 8 people outside the practice.
The "practice tools" will be a component of the follow-up
and will start after the training program. The implementa-
tion strategy will start in the first training session.
Motivational interviewing
Motivational interviewing (MI) will be introduced as a tool
for behavior change. The MI counseling technique is
patient oriented and suitable for brief office visits, and it
can be used to improve patient adherence to diet, exercise,
and smoking counseling in daily routine[36]. Since the MI
technique plays an important role in our study protocol, we
have described it in more detail in Additional file 2.
Content
The first step in MI is to set the agenda for the consultation
together with the patient[36]. "Agenda setting" will be an
issue to keep in the back of your mind from the very
beginning of the first interview. The basic question here
will be, "What are we going to talk about?" The patient
will be encouraged to choose one or more key items in
this agenda setting. This will make consultations more
structured and will lead to a more concrete action plan.
After this, the primary care nurse will assess the patient's
current behavior and motivation for change by rating and
exploring importance and confidence with respect to the
chosen key items. She will do this by reflective listening,
summarizing, asking open questions, scaling, supporting
self-efficacy, rolling with resistance, expressing empathy,
and developing discrepancy. If there is a need and suffi-
cient motivation for change regarding one or more items,
the primary care nurse will consult with the patient to
select one item as the goal for behavior change.BMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
Page 6 of 12
(page number not for citation purposes)
Structure
The MI training will be developed in cooperation with a
professional trainer, who will also tutor the complete
training program. Activities will include group discussions
and role plays on specific skills such as use of the ambiv-
alence, supporting self-efficacy, and reflective listening.
Video fragments created by a professional involved with
MI will be shown, and some video recordings of primary
care nurses will be discussed to learn about good and not-
so-good points of lifestyle counseling. After each training
session, the primary care nurses will have homework: they
will study the theory from the training session and apply
this theory to at least two patients with diabetes (cases).
The instruction to the primary care nurse will be to write
down the two consultations and to take these cases to the
next training.
Protocol for diabetes care
The Dutch guidelines for type 2 diabetes mellitus give rec-
ommendations for diagnostics and management to
patients with diabetes[18]. However, some recommenda-
tions, such as which tasks are to be delegated to primary
care nurses and how long a diabetes consultation should
last, will have to be adapted to each practice in a localized
protocol. During the training, the differences and agree-
ments of several diabetes protocols from general practices
will be discussed with the primary care nurses in order to
show that there is more than one way to carry out diabetes
care.
Social map
Practical information will be needed in the practice, e.g.,
about local diet and exercise programs, so that patients
can learn about these programs from the primary care
nurse. They will be encouraged to set up a network for (1)
contacting local dieticians to make appointments about
referral and treatment plans, and (2) gathering local exer-
cise programs and determining whether local government
offices or other parties will fund exercise programs (lead-
ing to a social map). During the training, the social map
will be discussed, and primary care nurses who already
have a social map in the general practice will share their
ideas with other primary care nurses who do not have a
social map in their general practice.
Practice tools
The following educational and supportive tools will be
distributed after the training program: a laminated
instruction chart with counseling techniques, record keep-
ing information, and recommendations for regular tele-
phone follow-ups to patients with diabetes; a help desk
for primary care nurses; and a follow-up meeting for pri-
mary care nurses. We will ask the primary care nurses to
keep up a record of consultation data, such as the stage of
change of the patient with regard to diet, physical activity,
smoking, and alcohol. The record keeping, like the
instruction chart, will be a useful and practical reminder
during consultations. The trainer will advise the primary
care nurses to monitor patients every 3 months according
to the treatment guidelines, to do MI, and to follow up
regularly by telephone, which will be every month for the
1st half year and will probably decrease after that.
The research team will function as a help desk; primary
care nurses will be able to call the research team for infor-
mation, who will follow up with three phone calls to
inquire about the development of the primary care nurses'
health counseling. The nurses' difficulties with the coun-
seling technique will be mentioned to this team and they
will look for solutions. When primary care nurses con-
sider a follow-up meeting (an afternoon) important, this
meeting will take p[lace. These supportive tools will be
used in the follow-up period for maintenance of the MI
training.
Effect evaluation
The aim of the effect evaluation will be to determine
whether the implementation strategy has achieved the
intended effects on the care process and the patients' clin-
ical outcomes. The research question will be, "What are
the effects of an implementation strategy aimed at
improving MI skills of primary care nurses compared to
the effects of usual care on the care process, the metabolic
parameters (such as HbA1c, blood pressure, and lipids),
lifestyle (diet, exercise, smoking and alcohol consump-
tion), health-related quality of life, and patients' willing-
ness to change their behavior?"
Variables and measures
Figure 2 and Table 1 give a detailed overview of the out-
come measures and instruments. The outcome measures
will be the care process, the patients' metabolic parame-
ters HbA1c, blood pressure, lipids [low-density lipopro-
tein (LDL) and total cholesterol], lifestyle (diet, exercise,
smoking, and alcohol consumption), health-related qual-
ity of life, and the patients' willingness to change their
behavior. Working with MI and diabetes check-ups car-
ried out by primary care nurses will provide the two meas-
ures of the care process. Data about the degree to which
the nurses work according to the MI principles will be
obtained from the record keeping, and data from medical
files will help us gain insight into the diabetes check-ups.
The metabolic parameters will be obtained from medical
files. The current state of the art in measuring lifestyle
changes is a multi-method approach that combines feasi-
ble self-reporting and reasonably objective measures.
The patients will also report specific behaviors relating
to smoking[37], saturated fat intake[38], fruit and vegeta-
ble consumption[39], physical activity[40,41] and
alcohol use[42] by means of validated self-reportedBMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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Table 1: Effect evaluation: outcome variables and instruments used to measure them
Outcome variables Dutch guideline norms Instruments
Care process
Effects of MI - Record keeping
Results of diabetes check-ups - Medical files
Metabolic parameters
HbA1c < 7% Medical files
Blood pressure < 140 mm Hg Medical files
Lipids:
LDL < 2.5 mmol/L Medical files
Total cholesterol < 4.5 mmol/L Medical files
Lifestyle
Diet:
Fruit and Vegetables 2 pieces fruit (200 g or more) and 200 g 
vegetables or more
Validated questionnaire, 8 items [39]
Fat consumption Total fat < 35 energy percent
Saturated fat < 10 energy percent
Validated questionnaire, 35 items [38]
Physical activity 30 min for 5 days/week Questionnaire, modified Dutch version of the 
CHAMPS, unvalidated, 15 items [40,41]
Personal activity meter with diary for 7 days
Smoking No smoking Validated questionnaire, 2 items [37]
Alcohol consumption Man: maximum 2 glasses Validated questionnaire, 2 items [42]
Woman: maximum 1 glass
Quality of life - Validated questionnaires, EQ-5D 5 items and 
VAS 1 item [43,44]
Patients' willingness to change behavior -Q u e s t i o n n a i r e
Flowchart showing relationship of the strategy, characteristics, variables, and indicators Figure 2
Flowchart showing relationship of the strategy, characteristics, variables, and indicators.BMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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questionnaires. We will use an objective measurement,
the personal activity meter (PAM), with a diary for record-
ing physical activity for 7 days. A combination of subjec-
tive and objective reporting will be chosen to get insight
into the amount of exercise. A self-reported questionnaire
will be used to measure the health-related quality of
life[43,44] and the patients' willingness to change their
behavior. This willingness to change will be determined
on the basis of answers to questions about the importance
and the confidence to change. Other factors that will be
recorded include background characteristics about the
patient (sex, education, etc.), the nurse (sex, age, etc.) and
the general practice (year of establishment, consultation
characteristics, etc.).
Timing of measurements
Information will be collected before intervention starts
(T0), as well as at the end of the trial 14 months later (T1)
for the intervention and control arms:
- At T0 (baseline), the research team will collect data from
medical files, such as HbA1c concentration, blood pres-
sure, and lipid values. Eligible patients will receive the first
questionnaire from our research team (with a invitation
letter from the GP) to assess their lifestyle and quality of
life. Primary care nurses will instruct participating patients
to carry a personal activity meter for 1 week, and to keep
a diary, noting his/her physical activity for that week.
- At T1, the second and final questionnaire, PAM and diary
will be sent to the patient's home address. The primary
care nurse will collect data from medical files regarding
medical parameters from the most recent patient contact.
The questionnaires, personal activity meters, diaries, and
recording forms for medical file research are to be sent to
the research team in a postage-paid envelope after com-
pletion. All these materials will carry a unique patient
number, and the patient number will be related to the
involved general practice number.
Data analysis
Dichotomization of the patient outcomes. The HbA1c
concentration must be less than 7%; blood pressure, less
than 140 mm Hg; the LDL, less than 2.5 mmol/L; and the
total cholesterol, less than 4.5 mmol/L [18]. Patients must
eat two pieces of fruit and 200 g of vegetables per day,
must exercise 30 minutes a day at least 5 days a week,
must consume less than 10 energy percent in saturated fat,
must not smoke, and must consume no alcohol or only a
moderate amount[45]. Descriptive statistics will be used
to summarize factors of general practice, primary care
nurse and patient factors for the two study arms and to
check for comparability in baseline variables between the
control arm and the intervention arm. We will use logistic
regression techniques accounting for two levels (patient
and practice) to statistically compare the intervention and
control arms. The baseline measurement will be used in
the model as a co-variant. Since different staff members in
one practice are involved in the treatment of the diabetes
nowadays (care given at practice level), we will have to
choose the level of the practice. Exploratory analyses are
also planned to examine the effect of explanatory factors
(e.g., sociodemographic factors) on the outcome.
Process evaluation
The purpose of the process evaluation will be to establish
the actual exposure and to investigate the feasibility of the
implementation strategy. The research question is, "To
what extent do primary care nurses take part in the imple-
mentation strategy, and what do the nurses and patients
think of this strategy?"
Variables and measurements
To establish exposure, we will measure the degree of
application of the training program. Each nurse will be
instructed to record 8 to 10 diabetes consultations before
and after the trial to determine their actual MI usage. Data
about the primary care nurses' actual exposure to the other
components of the implementation strategy (making a
diabetes protocol and social map) will be established in
the training.
At the end of the study, the nurses will receive a question-
naire about the feasibility of the implementation strategy.
This questionnaire consists of questions about their expe-
rience with the implementation strategy, such as, "Do you
think the MILD project would be useful to other nurses?"
and "Looking back, would you participate in the MILD
project again?" Patients will also be asked to fill in a ques-
tionnaire about their satisfaction with the diabetes con-
sultations with questions such as, "What did you think of
the diabetes consultations last year?" For a more detailed
overview of the process measures and instruments, see
Figure 2 and Table 2. This process evaluation can shed
light on obstacles and facilitators that can be used for
broader implementation.
Data analysis
We will explore the influences on the model introduced
by differences in the primary care nurses' accurate per-
formance of MI. Video recordings of diabetes consulta-
tions in the intervention and control arms will be scored
with the existing checklist, the BECCI, to determine the
extent to which the MI technique was implemented[46].
Descriptive statistics will be used to summarize the
patients' opinions of the diabetes consultations and the
nurses' opinions of the feasibility of the implementation
strategy.BMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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Economic evaluation
The economic evaluation will estimate the cost-effective-
ness of the MILD implementation intervention. The
research question will be, "What is the incremental cost-
effectiveness of our implementation strategy compared to
usual care given by a primary care nurse?"
Measurements and variables
Cost-effectiveness analysis will be done from a healthcare
perspective with a lifetime horizon because changes in
glycemic control affect long-term complication risks. In a
previous study, we show that adherence to the diabetes
guidelines is cost-effective from a perspective of a lifetime
horizon[47,48]. The costs of the implementation strategy
will be included, such as costs of changes in the diabetes
organization, training the professionals in MI, and extra
telephone calls with the patients as well as the major
patient-related cost items (number and type of appoint-
ments and treatment). The effects measured in the model
evaluation will be the effects on the HbA1c concentration
as the primary outcome measure, and on exercise levels,
dietary habits, cardiovascular risk score, and alcohol con-
sumption as process indicators.
Data analysis
The economic evaluation will be a cost-effectiveness
study. The cost will be balanced against the effect meas-
ures in a standardized model approach. In this study, pol-
icy cost-effectiveness will also be analyzed in a Mason
model that includes the following sections[49]:
1. Developmental costs of the implementation
2. Training of primary care nurses
3. Activities of health professionals and patients during
the intervention period, e.g., clinic visits and telephone
contacts
4. Costs of treatment, e.g., for use of health care services,
drugs, specialist care, and complications.
Training and material costs will be based on real costs,
and national guidelines will be used[50] to calculate the
cost of professional activities. The actual number of
patients in the intervention arm will be used to calculate
the cost of the intervention activities per patient. The vol-
ume of the patient activities will be registered in the
patient files, while patients will be asked to record activi-
ties outside the general practice in a diary. We expect these
costs to be less than 20 euros per treated patient. On the
basis of earlier research, we know that this amount of
money is certainly cost-effective[51,52].
Time frame
We plan to randomize all general practices that declare
their willingness to participate in this study. The baseline
data collection will take place at the beginning of the
study during the 1st 7 months (Figure 3). The training will
start in month 4, and the follow-up meeting will be organ-
ized in month 12. There will be three telephone follow-
ups to inquire about the nurses' development of health
counseling in months 10, 14, and 16. Follow-up data col-
lection will take place in months 18–25 inclusive. The
time scheduled for the trial is 25 months.
Discussion
The design of a cluster, randomized, controlled trial is
optimal from the methodological perspective, and it
could shed light on the effectiveness of the individual
ingredients of this multifaceted intervention. The imple-
mentation strategy that will be evaluated in this trial is
characterized by its innovative aspects. There is a wide
range of interventions aimed at improving the provision
of diabetes care in primary care, but not much is known
yet on how to implement and integrate different interven-
tion strategies effectively within day-to-day care in general
practice[53,54]. If this intervention proves to be effective
and cost-effective, its implementation will be considered
and anticipated.
Selection bias is a widespread problem in cluster rand-
omized trials[55]. Some of the biases associated with the
use of cluster designs can be avoided with careful atten-
tion to the design. Identifying patients before randomiz-
Table 2: Process evaluation: the measures and the instruments used to determine their effects
Measures Instruments
Exposure
Lifestyle counseling with MI 8–10 Video recording, which will be scores with the checklist "BECCI" [46]
Diabetes protocol -
Social map -
Feasibility
Nurses' perception and experience of the implementation strategy Questionnaire
Patients' opinion of diabetes consultations QuestionnaireBMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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ing the practices will be impossible in our study design, so
we will use an independent recruiter to recruit the partici-
pants. In this way, we will take adequate precautions to
guard against threats to the internal validity of the design
suggested by Torgerson[56]. It is important to use a rand-
omized design in the study because there will inevitably
be other initiatives relating to diabetes that will begin dur-
ing our study period, and because we will need to check
for unknown effect mediators and moderators. We choose
to involve many practices with relatively few patients
instead of a few practices with relatively many patients for
two reasons. First, more practices will increase the chance
of successful implementation in more practices, and will
also decrease cluster contamination. We will get also more
information about the conditions necessary for imple-
menting our strategy in a large group of practices[57,58].
We assume that getting the practice motivated for struc-
tured care will not be very difficult, if they can get some
support from us for making their schedules. We also
assume that it will be easy to motivate the primary care
nurse to use the MI tool because an effective tool for dis-
cussing diet and exercise is currently not available in gen-
eral practice. However, the nurses will have to be
supported in their motivation to participate, especially in
the long run. Some suggestions from the literature that we
have already elaborated on in our intervention strategy are
MI training followed by a follow-up meeting, an instruc-
tion chart with counseling techniques, a record keeping
system for consultation data and behavioral change, and
regular telephone follow-ups to the primary care nurses.
These items can be helpful in maintaining motivation, as
well as getting feedback about the results[59].
In contrast to these assumes, we think that it is very diffi-
cult to receive the records of the nurses in order to estab-
lish the actual usage of MI. We will provide effort to get
the records of all primary care nurses, because these
records are very useful.
Furthermore, we expect that there will be more effects on
lifestyle outcome measures than on metabolic parameters
because a lifestyle change must occur before we can meas-
ure an effect on metabolic parameters. We expect the met-
abolic parameters to have stronger long-term effects.
Although we originally intended to use more objective
measures for the outcome measurements of the effect
evaluation, logistic and financial conditions often pre-
clude this. A biomarker for fruit and vegetables, such as
carotene measurement, is expensive. There is no simple
biomarker available for alcohol. The influence of infor-
mation bias resulting from subjective self-reports can be
reduced in the data analysis by taking the use of pre-inter-
vention scores (which have the same information bias)
into account. We will make use of practicable objective
measurements of physical activity. Personal activity
meters are known not to register all activities with accu-
racy, and the level of activity can vary from week to week,
but we have chosen to combine subjective and objective
data to get better insight into the amount of exercise.
There are a great many different actometers in circulation.
We have chosen an accelerometer, which is more accurate
Time frame for the Motivational Interviewing to Change the Lifestyle of Patients with Type 2 Diabetes Study Figure 3
Time frame for the Motivational Interviewing to Change the Lifestyle of Patients with Type 2 Diabetes Study. 
All numbers refer to months.BMC Health Services Research 2009, 9:19 http://www.biomedcentral.com/1472-6963/9/19
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than the pedometer that counts the number of steps
walked in a day[60,61].
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